Hormone replacement in postmenopausal women: Impact of progestogens on autonomic tone and blood pressure regulation

Menopause

Volumn 9, Issue 2, 2002, Pages 127-136

  Christ, Michael ^a   Seyffart, Karen ^a   Tillmann, Hanns Christian ^a   Wehling, Martin ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMADINONE; CONJUGATED ESTROGEN; CYPROTERONE ACETATE; ESTRADIOL; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROGESTONE; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE VARIABILITY; HORMONE SUBSTITUTION; HUMAN; NORMAL HUMAN; POSTMENOPAUSE; PREVALENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0036185031     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200203000-00008     Document Type: Article

References (47)

1. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association
2. Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow-up study of 14,786 middle-aged men and women in Finland
3. Corcoran memorial lecture: Hormones and vasoprotection
4. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
5. Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited
6. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
7. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study: A prospective, observational study
8. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
9. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
10. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction
11. The sympathetic nervous system and the renin-angiotensin-aldosterone system in cardiovascular disease
12. Effect of estrogen replacement therapy on heart rate variability and heart rate in healthy postmenopausal women
13. The protective effects of estrogen on the cardiovascular system
14. Attenuation of heart-rate variability in postmenopausal women on progestin-containing hormone replacement therapy
15. Heart rate variability: Standards of measurement, physiological interpretation and clinical use
16. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women
17. Frequency domain measures of heart period variability to assess risk late after myocardial infarction
18. Frequency domain measures of heart period variability and mortality after myocardial infarction
19. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction
20. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham heart study
21. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen
22. Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function
23. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects
24. In-hospital and 1-year mortality in 1,524 women after myocardial infarction: Comparison with 4,315 men
25. Climacteric vasomotor symptoms do not imply autonomic dysfunction
26. Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies
27. Need for a revision of the normal limits of resting heart rate
28. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease
29. Relationship of tachycardia with high blood pressure and metabolic abnormalities: A study with mixture analysis in three populations
30. Estrogen regulation of noradrenergic signaling in the hypothalamus
31. Progesterone, progestagens and the central nervous system
32. Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol
33. Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress
34. Sex difference in presynaptic adrenergic inhibition of norepinephrine release during normoxia and ischemia in the rat heart
35. The effect of progestins on behavioral stress responses in postmenopausal women
36. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women
37. Molecular mechanism of tissue-specific regulation of mouse renin gene expression by cAMP: Identification of an inhibitory protein that binds nuclear transcriptional factor
38. Blood pressure of adults by age and sex: United States 1960-1962
39. Estradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension
40. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy
41. A randomized trial on effects of hormone therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery disease
42. Ambulatory-not office-blood pressures decline during hormone replacement therapy in healthy postmenopausal women
43. The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: Role of cyclic AMP
44. Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins
45. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro
46. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
47. A pharmacological review of selective oestrogen receptor modulators